Clinical impact of a novel lipoprotein apheresis treatment on no‐option chronic limb‐threatening ischemia: Result from the REDUCTION VISCOSITY study

Author:

Kojima Shunsuke1,Nakama Tatsuya12ORCID,Suzuki Toshihiko3ORCID,Obunai Kotaro1,Watanabe Hiroyuki1

Affiliation:

1. Department of Cardiology Tokyo Bay Medical Center Urayasu Japan

2. Division of Vascular Surgery The Jikei University School of Medicine Tokyo Japan

3. Department of Nephrology, Endocrinology, and Diabetes Tokyo Bay Medical Center Urayasu Japan

Abstract

AbstractIntroductionLipoprotein apheresis (LA) is a possible adjunct treatment for no‐option chronic limb‐threatening ischemia (CLTI). This study aimed to assess the impact of a novel LA for no‐option CLTI.MethodsWe retrospectively assessed 19 patients with no‐option CLTI treated using the novel LA. The primary outcome was a change in the skin perfusion pressure (SPP) after treatment with LA, and the secondary outcomes were changes in the viscosity‐related laboratory parameters.ResultsThe wound‐healing rate was 68.4%. The SPP at 2–3 weeks after series of LA were significantly higher both in the dorsal (41 vs. 53 mmHg, p = 0.037) and plantar (50.0 vs. 61.0 mmHg, p = 0.018) sides, compared to those at baseline. The viscosity‐related laboratory markers were also significantly improved after the treatment; low‐density lipoprotein‐cholesterol (57.0 vs. 43.0 mg/dL, p = 0.002), fibrinogen (333 vs. 258 mg/dL, p < 0.001), and C‐reactive protein (0.99 vs. 0.42 mg/dL, p = 0.001).ConclusionThe novel LA significantly increased the SPP and improved relevant laboratory findings.

Publisher

Wiley

Subject

Nephrology,Hematology

Reference24 articles.

1. ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European stroke organization (ESO)the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS);Aboyans V;Eur Heart J,2017

2. Global vascular guidelines on the management of chronic limb-threatening ischemia

3. Predictors of Delayed Wound Healing after Endovascular Therapy of Isolated Infrapopliteal Lesions Underlying Critical Limb Ischemia in Patients with High Prevalence of Diabetes Mellitus and Hemodialysis

4. Factors Influencing Wound Healing of Critical Ischaemic Foot after Bypass Surgery: Is the Angiosome Important in Selecting Bypass Target Artery?

5. LDL-Apheresis Reduces P-Selectin, CRP and Fibrinogen- Possible Important Implications for Improving Atherosclerosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3